Lateral Flow Assay Market to Grow with a CAGR of 5.48% through 2030
The increase in the prevalence of infectious diseases is
expected to drive the growth of global lateral flow assay in the forecast
period, 2026-2030.
According to TechSci Research report, “Lateral
Flow Assay Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2030”, the Global Lateral Flow Assay Market was valued at USD 9.88 billion in 2024 and is expected to reach USD 13.61 billion by 2030 with a CAGR of 5.48% during the forecast period. This can be ascribed to the growing prevalence of infectious diseases across
the world along with the growing geriatric population. Similarly, increasing
demand for point care testing along with growing demand for home-based lateral
flow assay tests is expected to create lucrative growth during the forecast
period. Additionally, growing awareness about new tests for the easy detection
of infectious diseases is anticipated to boost market growth during the
forecast period. However, growing collaborations between major players along
with increasing initiative and investment by government organizations for the
development of new assay kits in developing regions like North America and
Europe is expected to enhance the demand for the later flow assay market during
the forecast period. Similarly, the availability of skilled professionals is
one of the major factors which will further boost the market growth over the
years.
However, strict
and time-consuming regulations for lateral flow assays carried out in labs to
detect diseases may hamper the growth of the global lateral flow assay market
during the forecast period. Similarly,
the lack of skilled professionals for handling the lateral flow assay test may
hamper the growth of the market. Also, the high cost of lateral flow assays and
lack of awareness about new assays can further restrict the growth of the global
lateral flow assay market. Also, easier to perform and less expensive than
laboratory testing can limit the growth of the market growth.
Browse over XX market data
Figures spread through XX
Pages and an in-depth TOC on "Global Lateral Flow Assay Market"
The global lateral flow
assay market is segmented into product, application, technique, test type, end user, regional distribution, and company.
Based on Application, the Veterinary Diagnostics segment is experiencing the fastest growth. This acceleration is driven by several converging factors. First, there’s increasing emphasis on animal health and food safety. Governments and international bodies such as the World Organization for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) increasingly mandate routine screening of livestock and companion animals to prevent disease outbreaks, especially zoonotic infections that can jump to humans. Second, livestock monitoring programs are expanding rapidly in emerging economies like China, India, and Brazil. These nations are experiencing rapid growth in meat and dairy production, spurring the need for efficient point-of-care diagnostics to detect infections like foot-and-mouth disease, avian influenza, and bovine respiratory syndrome before they spread. Veterinary clinics and pet owners are adopting lateral flow assays for routine companion animal health checks—screening for conditions such as heartworm, parvovirus, Lyme disease, and more. These tests are valued for their speed, ease of use, and affordability in veterinary practices. Additionally, technological advancements—including improved multiplexing, smartphone reader compatibility, and rugged designs for field use—have made LFA tools more practical and reliable in on-farm and rural settings. This has broadened adoption beyond urban animal clinics to remote and decentralized farm environments.
Based on the Region, Asia Pacific is projected to exhibit the fastest growth in the global Lateral Flow Assay Market. This accelerated expansion is largely attributed to rising healthcare investments, increasing prevalence of chronic conditions such as coronary artery disease and diabetes, and expanding access to minimally invasive treatment options. Countries like China, India, Japan, and South Korea are witnessing rapid urbanization, changing lifestyles, and a growing aging population—all contributing to a higher demand for interventional cardiology and vascular procedures. Government initiatives in countries such as India’s Ayushman Bharat and China’s Healthy China 2030 have significantly improved access to healthcare, particularly in rural and semi-urban areas. This has increased the number of diagnostic and therapeutic procedures that rely on balloon catheters. Additionally, local manufacturing of medical devices and favorable regulatory reforms are encouraging both global and domestic companies to expand their presence in the region.
Major companies operating in Global Lateral Flow Assay Market are:
- Thermo Fisher Scientific, Inc.
- Abbott Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Quidel Corporation
- Hologic, Inc.
- bioMérieux SA
- PerkinElmer, Inc.
- Danaher Corporation
- QIAGEN N.V.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North
America is expected to dominate The Global Lateral Flow Assay Market
on account due to the growing popularity of self-diagnosis along with increasing
public awareness about easy diagnostic tests across the region. Furthermore, increasing
the number of new entrants and approvals in the healthcare sector and growing
initiatives by government organizations for the development of new assays are
further contributing to the demand for lateral flow assays. Similarly,
government organizations are taking initiative and investing in the medical
field for the development of better healthcare infrastructures which will
further boost the growth of the market during the forecast period. Besides, the
growing demand for point care testing because of the increasing incidence of
chronic diseases along with the growing adoption of new assays among patients
and healthcare providers across the region is further expected to create
lucrative opportunities for market growth” said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based global management consulting
firm.
“Lateral
Flow Assay Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Kits & Reagents, Lateral Flow Readers,
Others), By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy
& Fertility Testing, Veterinary Diagnostics, Others), By Technique
(Sandwich Assay, Competitive Assay, Multiplex Detection Assay), By Test Type
(Lateral Flow Immunoassay, Nucleic Acid Lateral Flow Assay), By End User (Hospitals
& Clinics, Diagnostic Laboratories, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global lateral flow
assay market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global lateral flow
assay market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com